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Over the past several years, evidence has accumulated demonstrating the existence 
of at least two T  helper (Th) subpopulations involved in the activation of B lympho- 
cytes. The evidence has come from several experimental systems that can be grouped 
into two major categories. The first category involves anti-hapten responses in which 
only the total response is followed without regard to particular B cell clones in the 
responding population. The second category involves anti-hapten responses charac- 
terized  by  a  dominant,  well-defined  idiotype(s).  In  the  former  category,  several 
laboratories (1-6) have shown that at least two subpopulations of Th cells are required 
for an  optimum  anti-hapten  response.  One  population,  Thl,  requires  the  physical 
linkage of hapten to carrier, "cognate recognition" (2, 4-6) and appears to be an Ia- 
negative  population  (3-6).  The second  population,  Th2,  does  not  require  cognate 
recognition  to  function  (2,  4-6),  bears  I  region-encoded  products  (3-6),  can  be 
replaced by T  cell replacing factors (TRF)  (3,  5,  6), and  in one system appears  to 
recognize immunoglobulin (Ig) determinants in association with antigen (1). 
In the second category, the expression of the dominant idiotype (Id) associated with 
the  anti-hapten  response  depends  upon  two  Th subpopulations.  As  with  the  first 
category, Thl  are  absolutely  necessary  for  the  activation  of Id  ÷  B  cells,  and  the 
physical linkage of hapten to carrier is required in their collaborative function with 
B cells (7, 8). Th2 cells have specificity for idiotypic determinants found on Ig (7-9) 
and appear to depend on the presence of circulating idiotypes in vivo for their normal 
development (8).  In reconstitution experiments there is evidence that the Id-specific 
Th2 population is carrier dependent but does not require a hapten-carrier conjugate 
for the activation of the dominant idiotype-bearing B cells (8). 
The information to date leaves open the question of whether the Th2 cells from the 
two categories are  in  fact similar  or represent  quite  different Th  populations.  We 
present evidence, using the previously described phenyltrimethylamino (TMA) hapten 
system (10,  11),  that  Lyt-1  ÷ Id-specific Th2 cells, like the Th2 cells of category one, 
bear I region gene products (I-J) and appear to activate Id  ÷ B cells by elaborating a 
soluble factor(s). 
Materials and Methods 
Immunizations.  Male A/J mice aged 6-8 wk (The Jackson Laboratories, Bar Harbor, ME) 
were immunized intraperitoneally either with  100 #g of keyhole limpet hemocyanin (KLH) 
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(Calbiochem-Behring Corp., San Diego, CA) or ovalbumin (OVA)  (Sigma Chemical Co., St. 
Louis, MO) emulsified in Freund's complete adjuvant to obtain carrier-specific T  cells. B cells 
were primed intraperitoneally with 1.0/~g of TMA coupled to Escherichia coli lipopolysaccharide 
(LPS) (Sigma Chemical Co.)  (12). The hapten conjugates, TMA-KLH and TMA-OVA, were 
prepared as described (10). 
Preparation and Treatment of T  Cells.  1 wk after immunization, nylon wool-passed T  cells or 
immunosorbent  nonadherent  cells were  treated with  monoclonal  anti-Lyt-2 antibodies and 
rabbit-anti-arsanilate affinity-purified antibodies (B-D FACS Systems, Becton,  Dickinson & 
Co., Sunnyvale, CA) followed by treatment with low toxic rabbit complement (C)  (Cedarlane 
Laboratories Ltd.).  In some experiments, T  cells were  first  treated with  anti-Lyt-2 plus C, 
followed by a two-step treatment  (I0  7 cells/ml) with anti-I-J antisera (1:10)  and C  (3). Anti-I- 
J  antisera were  prepared by immunizing B10.A  (3R)  mice with  concanavalin A  (Con  A)- 
activated T  blasts from B10.A (5R)  mice as previously described (3).  Sera were exhaustively 
absorbed with cells from C57B1/6 J  mice as described (3). 
Removal ofldiotype-specific  T Cells.  The method of Woodland and Cantor (7) was used, except 
that culture dishes were prepared with 200 #g of Na2SO4-precipitated normal A/J Ig or affinity- 
purified A/J anti-TMA antibody (60% Id  ÷) (10).  Briefly, T  cells (3 X  106 to 5 ×  106 cells/ml) 
were incubated on plates for 40 min at 37°C, the nonadherent population collected, and the 
procedure repeated. Nonadherent cells (60-80% recovery) were then washed and treated with 
anti-Lyt-2 plus C. 
Preparation  of  Con  A  Supernatants.  Normal  A/J  spleen  cells  were  cultured  with  Con  A 
(4  #g/107  cells/ml)  for  24  h  at  37°C  in  complete media.  The  supernatant  was  collected, 
absorbed with Sephadex G-75, filter sterilized, and stored at -90~C until use (3). 
Preparation of B  Cells.  TMA-LPS-primed spleen cells were treated with anti-Thy-1 mono- 
clonal antibody secreted by the hybridoma T24/40.7  (kindly provided by J. Kappler and  P. 
Marrack, National Jewish Hospital, Denver, CO.) and C  (3).  Routinely, ~60% viable spleen 
cells were recovered. 
Culture Conditions and Assay.  Cells were cultured in RPMI 1640 (GIBCO Laboratories, Grand 
Island Biological Co., Grand Island NY) supplemented with 5% fetal calf serum, 25 mM Hepes, 
5  X  10 -5  M  2-mercaptoethanol,  penicillin,  and  streptomycin.  Helper  T  cell  activity was 
determined by titration into triplicate cultures containing 3 X  106 hapten-primed B cells, and 
1 #g/ml of appropriate antigen was added. 4 d  after culture, cells from identical wells were 
pooled and  assayed for total anti-TMA plaque-forming cells (PFC)  using TMA-substituted 
sheep erythrocytes (10). Background PFC were detected using unsubstituted erythrocytes. CRI + 
PFC  were  determined  by  incorporating  10  #1  of anti-idiotypic antisera  (anti-Id,  10 #g  Id- 
binding capacity per  ml)  into  the  plaquing  medium.  The  percent  inhibition of PFC  was 
calculated according to the formula: percent inhibition =  ([1 -  total PFC (anti-Id)]/total PFC) 
X  100 =  percent CRI  + PFC. 
Results and  Discussion 
In a  preliminary communication  (13)  we reported that  at  least two  Lyt-l+,2  -  Th 
populations are required  to  trigger anti-TMA  PFC  response in  vitro, of which  40- 
80% produce a  cross-reactive idiotype(s) (CRI-TMA). As seen in Table I, Lyt-1+,2 -  T 
cells from either OVA- or KLH-primed mice added to TMA-primed B  cells support 
a  secondary anti-TMA PFC response of which 50-60%  secrete the CRI  (lines 3  and 
8). Furthermore, the data establish the participation of helper T  cells in activating B 
cells via a  homologous hapten-carrier bridge (compare lines 3, 4, 5, with 6,  7, and 8). 
If the T  cell populations are first incubated  in petri dishes coated with CRI + anti- 
TMA  antibodies and the nonadherent T  cells added to the cultures, there is a marked 
reduction in total TMA  PFC as well as the percent CRI + PFC (lines 9 and  11). TMA- 
specific PFC  responses are not  altered if the primed T  cells are incubated  on  petri 
dishes coated with normal mouse Ig, demonstrating the specificity of the absorption 
procedures (lines  10 and  12). The depleted T-OVA  population can be reconstituted 
by the addition of unfractionated T-KLH,  provided free KLH  is also present in the JAYARAMAN ET AL.  BRIEF DEFINITIVE REPORT  643 
TA~LZ I 
CRI + PFC Formation Depends on Lyt-I +,2- Tn Cells Having Apparent Specificity for Both Idiotype(s) 
and Carrier Antigen* 
Total TMA  Percent CRI  ÷ 
T cells in culture  Line number  Antigen in vitro  PFC/cuhure  PFC 
B cells only  1  TMA-OVA  44  22 
B cells only  2  TMA-KLH  36  12 
T-OVA  3  TMA-OVA  220  59 
T-OVA  4  TMA-KLH  48  8 
T-OVA  5  TMA-KLH +  OVA  64  10 
T-KLH  6  TMA-OVA  44  11 
T-KLH  7  TMA-OVA +  KLH  57  14 
T-KLH  8  TMA-KLH  224  50 
T-OVA (CRI-absorbed)  9  TMA-OVA  72  10 
T-OVA (NM Ig absorbed)  10  TMA-OVA  210  56 
T-KLH (CRI absorbed)  I 1  TMA-KLH  40  2 
T-KLH (NM Ig absorbed)  12  TMA-KLH  2 t0  52 
T-OVA ~CRI absorbed)  '1  13  TMA-OVA  80  14 
+  T-KLH  ~  14  TMA-OVA +  OVA  85  10 
15  TMA-OVA +  KLH  240  65 
* The appropriate Lyt-l+,2  -  T  cells were added at 4 X  10  ~ cells/culture (previously  determined to be optimum [13]) to 
triplicate cultures containing 3 X  10  s TMA-primed B cells. In lines  13,  14, and 15, 2 X  10  6 T-KLH were added to 4 X 
10  CRI absorbed T-OVA. The cultures were stimulated with the appropriate hapten-carrier conjugates and when 
necessary  with free carriers (lines  14 and 15). 4 d later the cultures were harvested and the total, as well as percent CRI  + 
direct PFC/culture determined. This table is representative of seven separate experiments. 
culture (compare lines 3, 9,  13,  14, and 15). If, however, the same T-KLH population 
is first absorbed on CRI-coated dishes, thus removing potential Id-specific cells, they 
can no longer reconstitute the CRI  ÷ PFC response in the presence of free KLH (data 
not shown). These results suggest the requirement of Id-specific Th2 and its activation 
by specific free carrier to obtain a  PFC response dominated by CRI. Overall, these 
results  suggest  the participation  of two classes of Th in  activating TMA-specific B 
cells. This agrees well with other idiotype systems (7-9), which have similarly described 
the need for two Th. 
Tada et al.  (4)  have reported the existence of a  Th subpopulation that is I-J  + and 
does not require hapten linked to the carrier to function. To determine whether an I- 
J+ Th cell(s) was involved in the Id  + TMA response, the Lyt-l+,2  -  T-KLH were first 
treated with  anti-I-J serum plus complement  (C)  before addition  into culture.  Our 
anti-I-J serum was produced against Con A T cell blasts, a method we have previously 
shown  to  induce  highly  T  cell  reactive anti-Ia  sera  (3).  As  seen  in  Table  II,  this 
treatment  does not  result  in  the  loss  of total TMA  PFC,  but  there  is  a  significant 
reduction  in  the percent  CRI  + PFC  compartment  (line  2).  To determine  the com- 
pleteness of the anti-I-J serum treatment, the treated T  cells were added up to 1 X  106 
in culture with no increase in CRI  + PFC (data not shown). To test whether it is the 
Th2 cells that bear I-J region gene products, the T-KLH were first treated with anti- 
I-J  serum  plus  C  before  addition  into  cultures  containing  a  T-OVA  population 
depleted of Th2 cells. As in the previous experiment, this treatment did not reduce the 
total  TMA  response  but  did  prevent  the  T-KLH  from  restoring  the  CRI  +  PFC 
(compare lines 4,  6,  and  7).  The possibility remained,  however, that  the Id-specific 
and the I-J  + Th were separate synergizing populations, and the removal of either one 
from our T-KLH population  would  prevent restoration  of the CRI  + PFC.  To rule 
this  out,  we  mixed  a  population  of T-KLH  depleted  of Id-specific cells  (by plate 
absorption)  with T-KLH depleted by anti-I-J plus C  treatment.  If separate popula- 
tions  existed,  they  would  complement  each  other  in  this  mixture.  However,  in 644  JAYARAMAN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Id-specific Lyt-1 +,2- Th Cells Bear the I-J Subregion-encoded Gene Products* 
Line 
T  cells in culture  T  cell treatment  number  Antigen in vitro 
Total 
Percent 
TMA  CRI* 
PFC/cul-  PFC 
ture 
T-KLH  C only  1  TMA-KLH  274  45 
T-KLH  Anti-I-J +  C  2  TMA-KLH  362  19 
T-KLH  Anti-I-J +  C (BI0,A  3  TMA-KLH  280  44 
(5R)  absorbed) 
Unfractionated T-OVA  --  4  TMA-OVA  262  45 
T-OVA (CRI absorbed)  --  5  TMA-OVA  136  12 
T-OVA (CRI absorbed) 
6  TMA-OVA +  KLH  394  71 
+  T-KLH  C only 
T-OVA (CRI absorbed) 
7  TMA-OVA +  KLH  300  7 
+  T-KLH  Anti-I-J +  C 
T-OVA (CRI absorbed) 
+  T-KLH  Anti-I-J +  C (BI0.A  8  TMA-OVA +  KLH  372  61 
(5R)  absorbed) 
* Nylon wool-passed  T  cells were first treated with anti-Lyt-2 plus C followed  by treatment with anti-l-J sera plus C as 
described in Materials and Methods. Cultures were performed as in Table I. This table is representative of six similar 
experiments with the exception of the absorption experiment using B 10~A (5R) spleen cells which was performed once. 
experiments  not  shown,  this  mixture  failed  to  reconstitute  an  Id-depleted T-OVA 
population in the presence of TMA-OVA and KLH (similar to line  7).  Lines 3 and 
8  demonstrate the specificity of the antiserum because absorption with  B10.A  (5R) 
lymphocytes removes anti-I-J specific activity. Unlike removal of Th2 on CRI-coated 
plates, the removal of Th2 by anti-I-J treatment did not reduce the total TMA PFC. 
This might be explained by the removal of an I-J  + suppressor inducer T cell for TMA. 
Such a  T  cell  (I-J  +, Lyt-1  +)  has been described by others  (14)  but requires a  Lyt-2  + 
cell for its expression. Such residual Lyt-2  + cells may contaminate either our T  or B 
cell preparations. Overall, these results demonstrate that Th2 Id-specific cells bear I- 
J-encoded determinants and also define a new function and property of this cell type, 
i.e., its requirement  for optimal CRI  + PFC formation and the apparent existence of 
surface  receptors  with  specificity  for  Ig  idiotypes.  Whether  this  latter  property  is 
universal for all Th2 cells involved in antihapten antibody responses remains unknown. 
We  (3)  and  others  (5)  have  described  a  Th2  population  that  bears  surface  Ia 
antigens  and  can  be replaced  by cell-free supernatants  from in  vitro  24-h  Con  A- 
stimulated splenic lymphocytes. To test whether such supernatants could replace the 
Id-specific, I-J  + Th2 cells, A/J spleen cells were stimulated with Con A  for 24 h  and 
the cell-free supernatant media (Con ASn) harvested. Con ASn was added to cultures 
depleted  of Th2  activity  by either  anti-I-J  +  C  treatment  or absorption  on  CRI  + 
coated  plates.  As  seen  in  Table  III, Con  ASn  added  to  intact  cultures  has  no 
significant effect (lines 4 and 9) but clearly restores the CRI  + PFC response in cultures 
that  have been depleted of Th2 activity (lines 6  and  11). These results suggest that 
Con ASn  can replace the Th2 cell.  However, it could be argued that certain T  cell 
growth factors in the Con ASn  amplify the few remaining Th2 cells that may have 
not been removed after the antiserum or plate-absorption procedures. This is unlikely, 
as the supernatant  from a  T  cell hybridoma, FS6-14.13  (kindly  provided by Dr. J. 
Kappler and Dr. P. Marrack), which produces T  cell growth factor but has no T  cell- 
replacing activity for antibody responses  (15),  does not  substitute  for the  idiotype- 
specific Th2  in  our hands  (data not  shown).  Moreover, Con  ASn  originating  from 
certain  non-H-2 a  strains  does  not  reconstitute  the  response  (data  not  shown),  a JAYARAMAN ET AL.  BRIEF  DEFINITIVE REPORT 
Txm.E III 
Con A Sn Replaces I-J ÷, Lyt-l+,2 -  Tn Specific for Idiotype* 
645 
Total TMA 
Line  Percent 
T  ceils in culture  T  cell treatment  Supplementation  number  PFC/cul- 
CRI  + PFC  tur¢ 
B cells only  --  --  1  12  5 
B cells only  --  Con ASn  2  20  8 
T-OVA  C  only  --  3  165  55 
T-OVA  C  only  Con ASn  4  210  43 
T-OVA  Anti-I-J +  C  --  5  180  17 
T-OVA  Anti-I-J +  C  Con  ASn  6  240  50 
B cells only  --  --  7  16  9 
T-OVA  --  --  8  120  81 
T-OVA  --  Coo ASn  9  105  62 
T-OVA (CRI absorbed)  --  --  10  50  6 
T-OVA (CRI absorbed)  --  Con ASn  11  138  67 
* Cultures were performed as in Tables I and II. Con A Sn was added into the cultures at a final 30% concentration on day 
1 ofcuhure. This table is representative of six separate experiments. 
restriction  we have so far observed only for idiotype-specific responses.  It should be 
noted in Table III (line 2) that B cells alone in the presence of antigen plus Con ASn 
are not activated to CRI  + TMA PFC above background, indicating the necessity for 
Thl cells in addition to Th2 activity. 
In conclusion, the results demonstrate that the Th2 cell necessary for the expression 
of a dominant Id(s) also shares characteristics of Tb2 cells described in systems where 
idiotypes  are  not  characterized.  Namely, the  Id-specific Th2  cell  bears surface I-J- 
encoded Ia antigens and can be replaced with cell-free supernatant media from 24-h 
Con A-stimulated spleen cells. The latter findings suggest the effect of Th2 on CRI  ÷ 
antibody-producing cells can be mediated by secreted T  cell factors. 
Summary 
An in vitro system for the study of idiotype (Id) expression on antitrimethylamino 
hapten antibody-producing cells and its regulation by two classes of helper T  cells is 
described.  These cells are distinguished  in  four ways:  one requires  a  hapten-carrier 
bridge and gives a good response that is low in Id; it does not bind to Id-coated dishes 
and is not affected by anti-I-J plus complement. The other requires antigen but not 
a  hapten-carrier bridge,  is bound  by Id-coated dishes  and  is  killed  by anti-I-J and 
complement. The Id-specific cell appears to be antigen specific and acts via a soluble 
factor(s). 
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